Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

European Electrotechnics reported for 3 months of 2025 by RAS

5/5/25 EELT

Court overturned the seizure of SMZ securities from buyers of shares on Moscow Exchange

5/5/25 MGNZ

SPB Exchange summarized the results of trading in April

5/5/25 SPBE

Raspadskaya reported for 3 months of 2025 by RAS

5/5/25 RASP

X5 launched cashback with shares

5/5/25 FIVE

M.Video-Eldorado renews its board of directors

5/5/25 MVID

Sollers reported for 3 months of 2025 by RAS

5/5/25 SVAV

Yuzhuralzoloto reported for 3 months of 2025 by RAS

5/5/25 UGLD

Board of Directors of Rosseti Tomsk recommended that dividends be paid for 2024

5/5/25 TORS

Tatneft reported for 3 months of 2025 by RAS

5/5/25 TATN